@article{c39262c88d7448e6a00ab8c32fa31041,
title = "Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial",
abstract = "Disabling stroke is costly and considered by some patients a fate worse than death. We aimed to determine whether clopidogrel reduces the rate and functional severity of stroke among high vascular risk patients, including patients with previous transient ischemic attack or ischemic stroke, who were enrolled in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial.",
author = "{CHARISMA Trial Investigators} and Hankey, {Graeme J} and Werner Hacke and Easton, {J Donald} and Johnston, {S Claiborne} and Jean-Louis Mas and Brennan, {Danielle M} and Bhatt, {Deepak L} and Fox, {Keith A A} and Topol, {Eric J}",
year = "2010",
month = aug,
doi = "10.1161/STROKEAHA.110.586727",
language = "English",
volume = "41",
pages = "1679--83",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams & Wilkins",
number = "8",
}